Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cells. (Q33962243)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cells.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Francesca Bruzzese

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Alessandra Leone

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Assunta Gagliardi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Elena Di Gennaro

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Alfredo Budillon

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Michele Puglia

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Monia Rocco

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Anna Gimigliano

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Biagio Pucci

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Alessandro Armini

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

1 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

3725-3742

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Histone deacetylase inhibitors: a new wave of molecular targeted anticancer agents.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

HDACi--targets beyond chromatin.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Multiple-target drugs: inhibitors of heat shock protein 90 and of histone deacetylase.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Histone deacetylase inhibitors in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Discovery and development of SAHA as an anticancer agent

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Development of vorinostat: current applications and future perspectives for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Identification of biomarkers in human head and neck tumor cell lines that predict for in vitro sensitivity to gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

2D-DIGE: comparative proteomics of cellular signalling pathways

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

The focusing positions of polypeptides in immobilized pH gradients can be predicted from their amino acid sequences

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Functional proteomics analysis of signal transduction pathways of the platelet-derived growth factor beta receptor

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or raltitrexed

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Enhancing the antitumor activity of ErbB blockade with histone deacetylase (HDAC) inhibition.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Characterization of side population cells from laryngeal cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Metabolism and proliferation share common regulatory pathways in cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Principles of cancer therapy: oncogene and non-oncogene addiction

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Involvement of glyceraldehyde-3-phosphate dehydrogenase in tumor necrosis factor-related apoptosis-inducing ligand-mediated death of thyroid cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Increased expression of enolase alpha in human breast cancer confers tamoxifen resistance in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

MBP-1 physically associates with histone deacetylase for transcriptional repression

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Retinoic acid-mediated down-regulation of ENO1/MBP-1 gene products caused decreased invasiveness of the follicular thyroid carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Epithelial-mesenchymal transition and the invasive potential of tumors.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Delta-crystallin enhancer binding factor 1 controls the epithelial to mesenchymal transition phenotype and resistance to the epidermal growth factor receptor inhibitor erlotinib in human head and neck squamous cell carcinoma lines

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

New strategies in head and neck cancer: understanding resistance to epidermal growth factor receptor inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Understanding resistance to EGFR inhibitors-impact on future treatment strategies

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Retracted: Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

A proteomic approach for evaluating the cell response to a novel histone deacetylase inhibitor in colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Inhibition of heregulin mediated MCF-7 breast cancer cell growth by the ErbB3 binding protein EBP1.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Ebp1 isoforms distinctively regulate cell survival and differentiation

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Human BRE1 is an E3 ubiquitin ligase for Ebp1 tumor suppressor

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

The translationally controlled tumour protein (TCTP)

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Complex relationship between TCTP, microtubules and actin microfilaments regulates cell shape in normal and cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

TCTP protects from apoptotic cell death by antagonizing bax function

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Tpt1 activates transcription of oct4 and nanog in transplanted somatic nuclei

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Neuroendocrine differentiation of LNCaP cells suggests: VDAC in the cell membrane is involved in the extrinsic apoptotic pathway

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Voltage dependent anion channel-1 regulates death receptor mediated apoptosis by enabling cleavage of caspase-8.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Induction of GRP78 by valproic acid is dependent upon histone deacetylase inhibition

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Transcriptional induction of GRP78/BiP by histone deacetylase inhibitors and resistance to histone deacetylase inhibitor-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Activation of the unfolded protein response contributes toward the antitumor activity of vorinostat

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Treatment with panobinostat induces glucose-regulated protein 78 acetylation and endoplasmic reticulum stress in breast cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Histone deacetylase inhibitors activate NF-kappaB in human leukemia cells through an ATM/NEMO-related pathway

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cells

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22).

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Heterogeneous nuclear ribonucleoprotein H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcription

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201100092

21 January 2018

Identifiers

10.1002/PMIC.201100092

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

release_r3wohgomrfc2zie2u5xv3lpzly

1 reference

https://api.fatcat.wiki/v0/release/r3wohgomrfc2zie2u5xv3lpzly

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21761561%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33962243&oldid=1964839056"